Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.70 |
| ▸ | P2RY10 | O00398 | 8/20 | 0.60 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | CDC25A | P30304 | 1/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | AKT1 | P31749 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.56 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RAD52 | P43351 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25665820 | 0.97 | FABP3 (0.70) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL26061597 | 0.97 | FABP3 (0.70) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL26018724 | 0.97 | FABP3 (0.70) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL14758262 | 0.97 | FABP3 (0.70) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL3630629 | 0.93 | FABP3 (0.72) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL3631867 | 0.93 | FABP3 (0.72) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL3629744 | 0.93 | FABP3 (0.72) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL12629387 | 0.91 | P2RY10 (0.69) | FABP3P2RY10GPR34DGKA | |
| SCHEMBL14080920 | 0.90 | FABP3 (0.61) | FABP3P2RY10GPR34LMNAESR1 | |
| SCHEMBL14669245 | 0.90 | P2RY10 (0.68) | FABP3P2RY10GPR34 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070167408-A1 | NOVEL ALKYL PHOSPHOLIPID DERIVATIVES WITH REDUCED CYTOTOXICITY AND USES THEREOF | ZENTARIS GMBH (DE) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167408-A1 | NOVEL ALKYL PHOSPHOLIPID DERIVATIVES WITH REDUCED CYTOTOXICITY AND USES THEREOF | PHOSPHO1, PTDSS1, PTDSS2 | FABP3 1765/4885P2RY10 984/4885GPR34 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.